Peter Klare Selected Research

Peter Klare Research Topics

Disease

12	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2007
7	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 02/2008
5	Triple Negative Breast Neoplasms 01/2022 - 06/2014
5	Neoplasms (Cancer) 10/2021 - 07/2008
3	Adenoma (Adenomas) 01/2020 - 02/2015
3	Carcinoma (Carcinomatosis) 10/2017 - 08/2012
3	Thrombocytopenia (Thrombopenia) 01/2017 - 08/2008
3	Neutropenia 01/2015 - 08/2008
2	Polyps 03/2019 - 01/2018
2	Hypoxia (Hypoxemia) 01/2016 - 12/2015
2	Nausea 11/2015 - 08/2008
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Neoplasm Metastasis (Metastasis) 10/2019
1	Abdominal Pain (Pain, Abdominal) 01/2017
1	Leukopenia 01/2017
1	Ascites 01/2017
1	Apnea 01/2016
1	Hypotension (Low Blood Pressure) 12/2015
1	Pathologic Complete Response 03/2015
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2015
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2015
1	Febrile Neutropenia 01/2015
1	Alopecia (Baldness) 08/2008
1	Vomiting 08/2008
1	Ovarian Epithelial Carcinoma 03/2008
1	Body Weight (Weight, Body) 08/2007

Drug/Important Bio-Agent (IBA)

7	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 02/2008
7	taxaneIBA 01/2021 - 08/2007
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 02/2008
5	AnthracyclinesIBA 01/2021 - 08/2007
4	PlatinumIBA 06/2014 - 03/2008
3	liposomal doxorubicin (Doxil)FDA Link 01/2022 - 03/2008
3	Propofol (Diprivan)FDA LinkGeneric 01/2020 - 12/2015
3	human ERBB2 proteinIBA 10/2017 - 08/2007
3	treosulfanIBA 01/2017 - 08/2012
2	Epirubicin (Ellence)FDA LinkGeneric 01/2022 - 01/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 10/2021 - 03/2015
2	Bevacizumab (Avastin)FDA Link 04/2020 - 06/2014
2	Capecitabine (Xeloda)FDA Link 04/2020 - 08/2007
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2017
2	Phenobarbital (Luminal)FDA Link 10/2019 - 10/2017
2	Alkylating AgentsIBA 12/2015 - 08/2012
2	Trastuzumab (Herceptin)FDA Link 06/2014 - 08/2007
2	Topotecan (Hycamtin)FDA LinkGeneric 08/2008 - 07/2008
1	Hormones (Hormone)IBA 10/2021
1	Everolimus FDA Link 04/2020
1	exemestane (Aromasin)FDA Link 04/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	SolutionsIBA 03/2019
1	Acetic Acid (Vinegar)FDA LinkGeneric 03/2019
1	Coloring Agents (Dyes)IBA 01/2018
1	cabazitaxel FDA Link 10/2017
1	Formaldehyde (Formol)FDA Link 10/2016
1	ParaffinIBA 10/2016
1	Midazolam (Versed)FDA LinkGeneric 01/2016
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 11/2015
1	Messenger RNA (mRNA)IBA 03/2015
1	Indicators and Reagents (Reagents)IBA 02/2015
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2015
1	pegfilgrastim (Neulasta)FDA Link 01/2015
1	SaltsIBA 06/2014
1	Gemcitabine FDA Link 07/2008
1	Etoposide (VP 16)FDA LinkGeneric 07/2008
1	Cytotoxins (Cytolysins)IBA 03/2008
1	1-dodecylpyridoxal (PLD)IBA 03/2008
1	dimemorfan (AT 17)IBA 02/2008
1	Monoclonal AntibodiesIBA 08/2007
1	CarbamatesIBA 08/2007
1	Taxoids (Taxanes)IBA 08/2007

Therapy/Procedure

9	Neoadjuvant Therapy 01/2022 - 06/2014
7	Drug Therapy (Chemotherapy) 10/2021 - 07/2008
5	Therapeutics 04/2020 - 03/2008
1	Surgical Instruments (Clip) 01/2015
1	Treatment Delay 08/2008